by QuantHealth
QuantHealth uses AI to simulate how patients will respond to therapies, so drug developers can test clinical trial decisions before enrolling anyone. It covers trial design, enrollment forecasting, indication selection and portfolio decisions.
Web appContact for pricing
Step 1: Book a meeting with QuantHealth.
Step 2: Define the trial protocol and cohorts to test.
Step 3: Set the investigational arm, control arm and endpoints.
Step 4: Review the simulated outcomes and enrollment predictions.
Step 5: Adjust the design and compare options before running a real trial.
The site says most tools analyze trial data after patients are enrolled, while QuantHealth predicts response before a trial begins.
Inclusion and exclusion criteria, the investigational arm, any control arm, and outcomes and endpoints.
The company says it has simulated more than 600 trials across 30 indications, with up to 90% predictive accuracy.
Yes. Use cases also include indication selection, market forecasting, asset diligence and portfolio prioritization.
Recursion OSRecursion is a clinical-stage TechBio company that uses an AI-enabled engine linking automated labs, models and clinical development to discover medicines. It advances a pipeline in oncology and rare disease.
Chai-1Multimodal foundation model for predicting biomolecular structures and interactions across proteins, ligands, nucleic acids, and complexes